BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Radioligand Assay

Below is an extended Radioligand Assay research listing. Click here to return to the Radioligand Assay main in depth entry.

Recent Publications on Radioligand Assay:

Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
With the aim to develop new potent and selective ligands of 5-HT(3)-type...
Direct Link
6th September, 2008
Dipartimento di Scienze Farmaceutiche, Universita di Catania, Catania,
1-[(Imidazolidin-2-yl)imino]indazole. Highly alpha 2/I1 selective agonist: synthesis, X-ray structure, and biological activity.
Novel benzazole derivatives bearing a (imidazolidin-2-yl)imino moiety at...
Direct Link
6th September, 2008
Department of Chemical Technology of Drugs and Department of
Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.
Structure-activity relationships (SARs) of 1 (SR141716) have been...
Direct Link
6th September, 2008
Chemistry and Life Sciences, Research Triangle Institute, Research
Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
We demonstrate here that covalent dimerization of 5-HT 1 ligands is an...
Direct Link
6th September, 2008
Department of Medicinal Chemistry, Theravance, Inc., 901 Gateway
[Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients] 2nd September, 2008
Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya
[Diagnostic value of protein tyrosine phosphatase-2beta antibody (IA-2betaA) in type 1 diabetes] 2nd September, 2008
Diabetic Center, Institute of Metabolism and Endocrinology, Second Xiangya
Glucagon-like peptide 1-receptor scans to localize occult insulinomas.
OBJECTIVE: Detection of antibodies to ribonucleoproteins represents a...
Direct Link
30th August, 2008
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
BACKGROUND: Palonosetron is a 5-HT(3)-receptor antagonist (5-HT(3)-RA)...
Direct Link
30th August, 2008
Research and Translational Development, MGI PHARMA INC, 6611 Tributary
Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren's syndrome : correlation with B cell biomarkers and disease activity.
OBJECTIVE: Detection of antibodies to ribonucleoproteins represents a...
Direct Link
21st August, 2008
Immunology, Necker Hospital, Paris, France.
Gamma-aminobutyric acid A receptor functional decrease in the hypothalamus during pancreatic regeneration in rats.
OBJECTIVE: In the present study, we investigated the alteration of...
Direct Link
21st August, 2008
Department of Biotechnology, Molecular Neurobiology and Cell Biology Unit,
Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Androgen receptor (AR)- and glucocorticoid receptor (GR)- mediated...
Direct Link
19th August, 2008
Department of Dermatology, Northwestern University, Chicago, Illinois,
Age-related changes in endothelin-1 receptor subtypes in rat heart.
Density, affinity, and subtype distribution of endothelin-1 (ET-1) binding...
Direct Link
8th August, 2008
CNR Institute of Clinical Physiology, Laboratory of Cardiovascular
Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo. 31st July, 2008
Department of Gastroenterology, Tenth Hospital, Tongji University,
Measurement of phosphoinositide 3-kinase and its products to study adipogenic signal transduction.
Adipogenesis is an important component of adipose tissue development and...
Direct Link
30th July, 2008
Department of Medicine, Microbiology and Immunology, University of Ottawa,
Flow cytometry application for studies on adenosine A2A receptors expression. 25th June, 2008
Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional